- Filed
- May 5, 2025 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 29.49M sh |
| Short Term Investments | Q1 2025 · Mar 31, 2025 | $315.31M |
| Short Term Investments | Q1 2025 · Dec 31, 2024 | $295.4M |
| Cash And Equivalents | Q1 2025 · Mar 31, 2025 | $53.88M |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $150.15M |
| Current Liabilities | Q1 2025 · Mar 31, 2025 | $63.47M |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $88.5M |
| Total Liabilities | Q1 2025 · Mar 31, 2025 | $95.07M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $118.69M |
| Current Assets | Q1 2025 · Mar 31, 2025 | $571.68M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $630.81M |
| Total Assets | Q1 2025 · Mar 31, 2025 | $730.81M |
| Total Assets | Q1 2025 · Dec 31, 2024 | $808.38M |
| Shares Diluted | Q1 2025 · Mar 31, 2024 | 29.62M sh |
| Stock Repurchased | Q1 2025 · Mar 31, 2024 | $0 |
| Capex | Q1 2025 · Mar 31, 2024 | $11.7M |
| Operating Cash Flow | Q1 2025 · Mar 31, 2024 | $8.86M |
| Stockholders Equity | Q1 2025 · Mar 31, 2024 | $589.02M |
| Stockholders Equity | Q1 2025 · Dec 31, 2023 | $572.51M |
| Eps Diluted | Q1 2025 · Mar 31, 2024 | −$0.34 |
| Eps Basic | Q1 2025 · Mar 31, 2024 | −$0.34 |
| Sga Expense | Q1 2025 · Mar 31, 2024 | $125.62M |
| Rd Expense | Q1 2025 · Mar 31, 2024 | $28.85M |
| Net Income | Q1 2025 · Mar 31, 2024 | −$10.01M |
| Operating Income | Q1 2025 · Mar 31, 2024 | −$15.22M |
| Gross Profit | Q1 2025 · Mar 31, 2024 | $139.25M |
| Revenue | Q1 2025 · Mar 31, 2024 | $164.01M |